Diagenode

Genome-wide redistribution of BRD4 binding sites in transformation resistant cells.


Si H, Scaffidi P, Merchant A, Cam M, Stahlberg E, Misteli T, Fernandez P

Hutchinson-Gilford progeria syndrome (HGPS) patients do not develop cancer despite a significant accumulation of DNA damage in their cells. We have recently reported that HGPS cells are refractory to experimental oncogenic transformation and we identified the bromodomain-containing 4 protein (BRD4) as a mediator of the transformation resistance. ChIP-sequencing experiments revealed distinct genome-wide binding patterns for BRD4 in HGPS cells when compared to control wild type cells. Here we provide a detailed description of the ChIP-seq dataset (NCBI GEO accession number GSE61325), the specific and common BRD4 binding sites between HGPS and control cells, and the data analysis procedure associated with the publication by Fernandez et al., 2014 in Cell Reports 9, 248-260 [1].

Tags
Bioruptor
Chromatin Shearing
ChIP-seq
Bioruptor Plus

Share this article

Published
March, 2015

Source

Events

 See all events

Twitter feed

News

 See all news